Roxadustat
Back to searchMolecule Structure
Scientific Name
Roxadustat
Description of the Drug
Roxadustat is a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor used to treat symptomatic anemia associated with chronic kidney disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04847
http://www.drugbank.ca/drugs/DB04847
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Hypoxia-inducible factor prolyl hydroxylase | PROTEIN FAMILY | INHIBITOR | CHEMBL3831261 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL523705 |
| Human Metabolome Database | HMDB0252245 |
| DrugBank | DB04847 |
| PubChem: Thomson Pharma | 16342072 |
| PubChem | 11256664 |
| Nikkaji | J3.176.363K |
| PDBe | 8HO |
| BindingDB | 50431015 |
| EPA CompTox Dashboard | DTXSID60230644 |
| DrugCentral | 5371 |
| Brenda | 220871 |
| ChemicalBook | CB82538253 |
| Guide to Pharmacology | 8454 |
| ChEBI | 132774 |
| ZINC | ZINC000071257465 |
